{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:22:12Z","timestamp":1784550132675,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12029-021-00697-9","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:02:33Z","timestamp":1630519353000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-402X","authenticated-orcid":false,"given":"Emine","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-9869","authenticated-orcid":false,"given":"Sibel","family":"Bektas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-4808","authenticated-orcid":false,"given":"Zekeriya","family":"Pelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6227-1189","authenticated-orcid":false,"given":"Irem","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-1229","authenticated-orcid":false,"given":"Ahmet Muzaffer","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7582-8078","authenticated-orcid":false,"given":"Ferhat","family":"Cengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0838-9220","authenticated-orcid":false,"given":"Perihan \u00d6zkan","family":"Gumuskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"697_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al.\u00a0Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.\u00a0CA Cancer J Clin. 2018;68:394\u2013424. PMID: 30207593.\u00a0https:\/\/doi.org\/10.3322\/caac.21492.","DOI":"10.3322\/caac.21492"},{"key":"697_CR2","doi-asserted-by":"publisher","unstructured":"Yang Y, Huang X, Sun J, et al. Prognostic value of perineural invasion in colorectal cancer: a meta- analysis. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2015;19:1113\u20131122. PMID:\u00a025663635.\u00a0https:\/\/doi.org\/10.1007\/s11605-015-2761-z.","DOI":"10.1007\/s11605-015-2761-z"},{"key":"697_CR3","doi-asserted-by":"publisher","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw.\u00a02018;16(7):874\u2013901. PMID:\u00a030006429. https:\/\/doi.org\/10.6004\/jnccn.2018.00.","DOI":"10.6004\/jnccn.2018.00"},{"key":"697_CR4","doi-asserted-by":"publisher","unstructured":"Ryan JE, Warrier SK, Lynch AC, et al. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Colorectal Dis Off J Assoc Coloproctol Great Br Irel. 2015;17:849\u2013861. PMID:26260213.\u00a0https:\/\/doi.org\/10.1111\/codi.13081.","DOI":"10.1111\/codi.13081"},{"key":"697_CR5","doi-asserted-by":"publisher","unstructured":"Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99:918\u201328. PMID:\u00a022362002.\u00a0https:\/\/doi.org\/10.1002\/bjs.8702.","DOI":"10.1002\/bjs.8702"},{"key":"697_CR6","doi-asserted-by":"publisher","unstructured":"de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol. 2011;18:1590\u20138. PMID:21207164.\u00a0https:\/\/doi.org\/10.1245\/s10434-010-1506-1.","DOI":"10.1245\/s10434-010-1506-1"},{"key":"697_CR7","doi-asserted-by":"publisher","unstructured":"Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemora-diotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30:1926\u201333. PMID:22529255.\u00a0https:\/\/doi.org\/10.1200\/jco.2011.40.1836.","DOI":"10.1200\/jco.2011.40.1836"},{"key":"697_CR8","doi-asserted-by":"publisher","unstructured":"Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N. Engl. J. Med. 2006;355:1114\u20131123. PMID: 16971718.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa060829.","DOI":"10.1056\/NEJMoa060829"},{"key":"697_CR9","doi-asserted-by":"publisher","unstructured":"Silberfein EJ, Kattepogu KM, Hu CY, et al. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010;17:2863\u20139. PMID:\u00a020552409.\u00a0https:\/\/doi.org\/10.1245\/s10434-010-1119-8.","DOI":"10.1245\/s10434-010-1119-8"},{"key":"697_CR10","doi-asserted-by":"publisher","unstructured":"Couwenberg AM, Burbach JPM, van Grevenstein WMU, et al. Effect of neoadjuvant therapy and rectal surgery on health-related quality of life in patients with rectal cancer during the first 2 years after diagnosis.\u00a0Clin Colorectal Cancer. 2018;17:e499\u2013e512. PMID:\u00a029678514.\u00a0https:\/\/doi.org\/10.1016\/j.clcc.2018.03.009.","DOI":"10.1016\/j.clcc.2018.03.009"},{"key":"697_CR11","doi-asserted-by":"publisher","unstructured":"Ashburn JH, Kalady MF. Radiation-\u0131nduced problems in colorectal surgery.\u00a0Clin Colon Rectal Surg. 2016;29:85\u201391. PMID: 27247532.\u00a0https:\/\/doi.org\/10.1055\/s-0036-1580632.","DOI":"10.1055\/s-0036-1580632"},{"key":"697_CR12","doi-asserted-by":"publisher","unstructured":"Delphine Dayde, Ichidai Tanaka, Jain R, et al. Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer J Mol Sci Mar. 2017;7;18(3):573. PMID:\u00a028272347.\u00a0https:\/\/doi.org\/10.3390\/ijms18030573.","DOI":"10.3390\/ijms18030573"},{"key":"697_CR13","doi-asserted-by":"publisher","unstructured":"Weiser MR. AJCC 8th Edition: Colorectal cancer. Ann Surg Oncol. 2018;25(6):1454\u20131455. PMID:\u00a029616422.\u00a0https:\/\/doi.org\/10.1245\/s10434-018-6462-1.","DOI":"10.1245\/s10434-018-6462-1"},{"key":"697_CR14","doi-asserted-by":"publisher","unstructured":"Nougaret S, Reinhold C, Mikhael HW, et al. The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the \u201cDISTANCE\u201d? Radiology. 2013;268:330\u201344. PMID:\u00a023882096.\u00a0https:\/\/doi.org\/10.1148\/radiol.13121361.","DOI":"10.1148\/radiol.13121361"},{"key":"697_CR15","doi-asserted-by":"publisher","unstructured":"Prampolini F, Taschini S, Pecchi A, et al. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion. Abdom Radiol (NY). 2020;45(10):2941\u20132949. PMID:\u00a030483843.\u00a0https:\/\/doi.org\/10.1007\/s00261-018-1838-z.","DOI":"10.1007\/s00261-018-1838-z"},{"key":"697_CR16","doi-asserted-by":"publisher","unstructured":"Mage AG, Pai RK, Stocchi L, et al. American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer. Dis Colon Rectum. 2015;58(1):32\u201344. PMID:\u00a025489692.\u00a0https:\/\/doi.org\/10.1097\/DCR.0000000000000266.","DOI":"10.1097\/DCR.0000000000000266"},{"key":"697_CR17","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-aguilar J, Hernandez de Anda E, Sirivongs P, et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treat- ed by mesorectal excision. Dis Colon Rectum. 2003;46:298\u2013304. PMID:\u00a012626903.\u00a0https:\/\/doi.org\/10.1007\/s10350-004-6545-x.","DOI":"10.1007\/s10350-004-6545-x"},{"key":"697_CR18","doi-asserted-by":"publisher","unstructured":"Yoon SM, Kim DY, Kim TH, et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2007;69:1167\u201372. PMID:\u00a017967307.\u00a0https:\/\/doi.org\/10.1016\/j.ijrobp.2007.04.047.","DOI":"10.1016\/j.ijrobp.2007.04.047"},{"key":"697_CR19","doi-asserted-by":"publisher","unstructured":"Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys. 2005;63:25\u201336. PMID:\u00a016111569.\u00a0https:\/\/doi.org\/10.1016\/j.ijrobp.2005.04.049.","DOI":"10.1016\/j.ijrobp.2005.04.049"},{"key":"697_CR20","doi-asserted-by":"publisher","unstructured":"Das P, Skibber JM, Rodriguez-Bigas MA, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007;109: 1750\u20131755. PMID:\u00a017387743.\u00a0https:\/\/doi.org\/10.1002\/cncr.22625.","DOI":"10.1002\/cncr.22625"},{"key":"697_CR21","doi-asserted-by":"publisher","unstructured":"Sun Y, Wu X, Lin H, et al. Lymph node regression to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: prognostic implication and a predictive model. J Gastrointest Surg. 2021;25(4):1019\u20131028. PMID:\u00a032219686.\u00a0https:\/\/doi.org\/10.1007\/s11605-020-04566-x.","DOI":"10.1007\/s11605-020-04566-x"},{"key":"697_CR22","doi-asserted-by":"publisher","unstructured":"Shivakumar L, Ansell S. Targeting B-lymphocyte stimulator\/B-cell activating factor and a proliferationinducing ligand in hematologic malignancies. Clin Lymphoma Myeloma. 2006;7:106\u2013108 PMID: 17026820.\u00a0https:\/\/doi.org\/10.3816\/CLM.2006.n.046.","DOI":"10.3816\/CLM.2006.n.046"},{"key":"697_CR23","doi-asserted-by":"publisher","unstructured":"ChenY, Chen K, Xiao X, et al. Pretreatment neutrophil-to-lymphocyte ratio \u0131s correlated with response to neoadjuvant chemotherapy as an \u0131ndependent prognostic \u0131ndicator in breast cancer patients: a retrospective study. BMC Cancer. 2016;19:16:320. PMID: 27198767.\u00a0https:\/\/doi.org\/10.1186\/s12885-016-2352-8.","DOI":"10.1186\/s12885-016-2352-8"},{"key":"697_CR24","doi-asserted-by":"publisher","unstructured":"Huh JW, Lee JH, Kim HR, et al.\u00a0Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg. 2013;206(5):758\u2013763.\u00a0PMID: 23835209.\u00a0https:\/\/doi.org\/10.1016\/j.amjsurg.2013.02.010.","DOI":"10.1016\/j.amjsurg.2013.02.010"},{"key":"697_CR25","doi-asserted-by":"publisher","unstructured":"Yang Y, Huang X, Sun J, et al. Prognostic value of perineural invasion in colorectal cancer: a meta-analysis J Gastrointest Surg. 2015;19(6):1113-22. PMID:25663635.\u00a0https:\/\/doi.org\/10.1007\/s11605-015-2761-z.","DOI":"10.1007\/s11605-015-2761-z"},{"key":"697_CR26","doi-asserted-by":"publisher","unstructured":"Nikberg M, Chabok A, Letocha H, et al. Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncologica. 2016;55(12):1418\u20131424.\u00a0PMID: 27732105.\u00a0https:\/\/doi.org\/10.1080\/0284186x.2016.1230274.","DOI":"10.1080\/0284186x.2016.1230274"},{"key":"697_CR27","doi-asserted-by":"publisher","unstructured":"Tripathi P, Rao SX, Zeng MS. Clinical value of MRI-detected extramural venous invasion in rectal cancer. J Dig Dis.\u00a02017;18(1):2\u201312. PMID:\u00a028009094.\u00a0https:\/\/doi.org\/10.1111\/1751-2980.12439.","DOI":"10.1111\/1751-2980.12439"},{"key":"697_CR28","doi-asserted-by":"publisher","unstructured":"Smith NJ, Barbachano Y, Norman AR, et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg. 2018;95:229\u201336. PMID:\u00a017932879.\u00a0https:\/\/doi.org\/10.1002\/bjs.5917.","DOI":"10.1002\/bjs.5917"},{"key":"697_CR29","doi-asserted-by":"publisher","unstructured":"Sohn B, Lim JS, Kim H, et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol. 2015;25:1347\u201355. PMID:\u00a025500963.\u00a0https:\/\/doi.org\/10.1007\/s00330-014-3527-9.","DOI":"10.1007\/s00330-014-3527-9"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00697-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-021-00697-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00697-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T05:16:01Z","timestamp":1648012561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-021-00697-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["697"],"URL":"https:\/\/doi.org\/10.1007\/s12029-021-00697-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-785035\/v1","asserted-by":"object"}]},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"23 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval for this study was granted from XXXX Hospital Ethics Committee for Clinical Studies in July 2020 (reg:83).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was not required due to the retrospective use of de-identifed administrative data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}